BW-20507

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameBW-20507
Drug Alias NameBW-20507BW20507
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHBsAg inhibitorsRNA interferenceAsialoglycoprotein receptor binders
TargetsHepatitis B Surface AntigensAsialoglycoprotein receptor
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandAustraliaHong Kong +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Bolin Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co LtdArgo Biopharma Australia Pty LtdHangzhou Bolin Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A